Human hepatocyte growth factor (VM202) gene therapy via transendocardial injection in a pig model of chronic myocardial ischemia

Journal of Cardiac Failure

Volumn 17, Issue 7, 2011, Pages 601-611

  Perin, Emerson C ^a,d   Silva, Guilherme V ^a   Vela, Deborah C ^a   Zheng, Yi ^a   Baimbridge, Fred ^a   Gahremanpour, Amir ^a   Quan, Xin ^a   Hahn, Woong ^b   Kim, Jongmook ^b   Wood, Krissy ^c   Kitamura, Marina ^c  

^a ST LUKE S EPISCOPAL HOSPITAL   (United States)

^b ViroMed   (South Korea)

^c CHARLES RIVER LABORATORIES   (United States)

^d NONE   (United States)

Author keywords

Chronic myocardial ischemia; gene therapy; hepatocyte growth factor; myocardial perfusion

Indexed keywords

DOBUTAMINE; GENOMIC DNA; INTERLEUKIN RECEPTOR; SCATTER FACTOR; UNCLASSIFIED DRUG; VM 202;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; DRUG CLEARANCE; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; ELECTROCARDIOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL PIG; FOLLOW UP; GENE THERAPY; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEMODYNAMICS; HISTOPATHOLOGY; LOW DRUG DOSE; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 79959559295     PISSN: 10719164     EISSN: 15328414     Source Type: Journal    
DOI: 10.1016/j.cardfail.2011.03.004     Document Type: Article

References (38)

1. W. Rosamond, K. Flegal, K. Furie, A. Go, K. Greenlund, and N. Haase Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee Circulation 117 2008 e25 e146
2. W.C. Stanley Myocardial energy metabolism during ischemia and the mechanisms of metabolic therapies J Cardiovasc Pharmacol Ther 9 Suppl 1 2004 S31 S45
3. F.W. Sellke, and M. Ruel Vascular growth factors and angiogenesis in cardiac surgery Ann Thorac Surg 75 2003 S685 S690
4. S. Fuchs, N. Dib, B.M. Cohen, P. Okubagzi, E.B. Diethrich, and A. Campbell A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease Catheter Cardiovasc Interv 68 2006 372 378 (Pubitemid 44330674)
5. J. Kastrup, E. Jorgensen, A. Ruck, K. Tagil, D. Glogar, and W. Ruzyllo Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris. A randomized double-blind placebo-controlled study: the Euroinject One trial J Am Coll Cardiol 45 2005 982 988 (Pubitemid 40432426)
6. P.B. Shah, and D.W. Losordo Nonviral vectors for gene therapy: clinical trials in cardiovascular disease Adv Genet 54 2005 339 361 (Pubitemid 43580685)
7. F. Bussolino, M.F. Di Renzo, M. Ziche, E. Bocchietto, M. Olivero, and L. Naldini Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth J Cell Biol 119 1992 629 641
8. H. Nakagami, Y. Kaneda, T. Ogihara, and R. Morishita Hepatocyte growth factor as potential cardiovascular therapy Expert Rev Cardiovasc Ther 3 2005 513 519 (Pubitemid 40691920)
9. K. Matsumoto, and T. Nakamura Emerging multipotent aspects of hepatocyte growth factor J Biochem 119 1996 591 600 (Pubitemid 26131762)
10. V. Jayasankar, Y.J. Woo, T.J. Pirolli, L.T. Bish, M.F. Berry, and J. Burdick Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure J Card Surg 20 2005 93 101 (Pubitemid 40175309)
11. J. Gille, M. Khalik, V. Konig, and R. Kaufmann Hepatocyte growth factor/scatter factor (HGF/SF) induces vascular permeability factor (VPF/VEGF) expression by cultured keratinocytes J Invest Dermatol 111 1998 1160 1165 (Pubitemid 29115191)
12. R. Morishita, M. Aoki, Y. Yo, and T. Ogihara Hepatocyte growth factor as cardiovascular hormone: role of HGF in the pathogenesis of cardiovascular disease Endocr J 49 2002 273 284 (Pubitemid 34832297)
13. V. Jayasankar, Y.J. Woo, L.T. Bish, T.J. Pirolli, S. Chatterjee, and M.F. Berry Gene transfer of hepatocyte growth factor attenuates postinfarction heart failure Circulation 108 Suppl 1 2003 II230 II236
14. Y. Taniyama, R. Morishita, K. Hiraoka, M. Aoki, H. Nakagami, and K. Yamasaki Therapeutic angiogenesis induced by human hepatocyte growth factor gene in rat diabetic hind limb ischemia model: molecular mechanisms of delayed angiogenesis in diabetes Circulation 104 2001 2344 2350 (Pubitemid 33049519)
15. R. Morishita, M. Sakaki, K. Yamamoto, S. Iguchi, M. Aoki, and K. Yamasaki Impairment of collateral formation in lipoprotein(a) transgenic mice: therapeutic angiogenesis induced by human hepatocyte growth factor gene Circulation 105 2002 1491 1496 (Pubitemid 34263283)
16. K. Kawaida, K. Matsumoto, H. Shimazu, and T. Nakamura Hepatocyte growth factor prevents acute renal failure and accelerates renal regeneration in mice Proc Natl Acad Sci U S A 91 1994 4357 4361 (Pubitemid 24143432)
17. M.L. Liu, W.M. Mars, R. Zarnegar, and G.K. Michalopoulos Uptake and distribution of hepatocyte growth factor in normal and regenerating adult rat liver Am J Pathol 144 1994 129 140 (Pubitemid 24158366)
18. M. Carlsson, N.F. Osman, P.C. Ursell, A.J. Martin, and M. Saeed Quantitative MR measurements of regional and global left ventricular function and strain after intramyocardial transfer of VM202 into infarcted swine myocardium Am J Physiol Heart Circ Physiol 295 2008 H522 H532
19. M. Saeed, A. Martin, P. Ursell, L. Do, M. Bucknor, and C.B. Higgins MR assessment of myocardial perfusion, viability, and function after intramyocardial transfer of VM202, a new plasmid human hepatocyte growth factor in ischemic swine myocardium Radiology 249 2008 107 118
20. R.R. Edelman Can MR imaging be used to determine the efficacy of gene therapy in the heart? Radiology 249 2008 1 2
21. J.A. Fallavollita, and J.M. Canty Jr. Ischemic cardiomyopathy in pigs with two-vessel occlusion and viable, chronically dysfunctional myocardium Am J Physiol Heart Circ Physiol 282 2002 H1370 H1379
22. D.M. Roth, Y. Maruoka, J. Rogers, F.C. White, J.C. Longhurst, and C.M. Bloor Development of coronary collateral circulation in left circumflex ameroid-occluded swine myocardium Am J Physiol 253 1987 H1279 H1288
23. G.C. Hughes, A.P. Kypson, J.D. St Louis, B.H. Annex, R.E. Coleman, and T.R. DeGrado Improved perfusion and contractile reserve after transmyocardial laser revascularization in a model of hibernating myocardium Ann Thorac Surg 67 1999 1714 1720 (Pubitemid 29301316)
24. G.C. Hughes, C.K. Landolfo, B. Yin, T.R. DeGrado, R.E. Coleman, and K.P. Landolfo Is chronically dysfunctional yet viable myocardium distal to a severe coronary stenosis hypoperfused? Ann Thorac Surg 72 2001 163 168 (Pubitemid 32643027)
25. Y. Lee, E.J. Park, S.S. Yu, D.K. Kim, and S. Kim Improved expression of vascular endothelial growth factor by naked DNA in mouse skeletal muscles: implication for gene therapy of ischemic diseases Biochem Biophys Res Commun 272 2000 230 235 (Pubitemid 30444927)
26. K.R. Cho, J.S. Choi, W. Hahn, D.S. Kim, J.S. Park, and D.S. Lee Therapeutic angiogenesis using naked DNA expressing two isoforms of the hepatocyte growth factor in a porcine acute myocardial infarction model Eur J Cardiothorac Surg 34 2008 857 863
27. H.J. Kim, S.Y. Jang, J.I. Park, J. Byun, D.I. Kim, and Y.S. Do Vascular endothelial growth factor-induced angiogenic gene therapy in patients with peripheral artery disease Exp Mol Med 36 2004 336 344 (Pubitemid 39279529)
28. L. Gepstein, G. Hayam, and S.A. Ben-Haim A novel method for nonfluoroscopic catheter-based electroanatomical mapping of the heart. In vitro and in vivo accuracy results Circulation 95 1997 1611 1622 (Pubitemid 27142822)
29. E.C. Perin, G.V. Silva, R. Sarmento-Leite, A.L. Sousa, M. Howell, and R. Muthupillai Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging Circulation 106 2002 957 961 (Pubitemid 34925330)
30. E.C. Perin, G.V. Silva, R. Sarmento-Leite, W.K. Vaughn, R.D. Fish, and J.J. Ferguson 3rd Left ventricular electromechanical mapping: preliminary evidence of electromechanical changes after successful coronary intervention Am Heart J 144 2002 693 701
31. S. Fuchs, R.C. Hendel, D.S. Baim, J.W. Moses, A. Pierre, and R.J. Laham Comparison of endocardial electromechanical mapping with radionuclide perfusion imaging to assess myocardial viability and severity of myocardial ischemia in angina pectoris Am J Cardiol 87 2001 874 880 (Pubitemid 32244207)
32. R. Kornowski, M.K. Hong, and M.B. Leon Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability Circulation 98 1998 1837 1841 (Pubitemid 28509277)
33. R. Sarmento-Leite, G.V. Silva, H.F. Dohman, R.M. Rocha, H.J. Dohman, and N.D. de Mattos Comparison of left ventricular electromechanical mapping and left ventricular angiography: defining practical standards for analysis of NOGA maps Tex Heart Inst J 30 2003 19 26 (Pubitemid 36297654)
34. J. Lessick, G. Hayam, A. Zaretsky, S.A. Reisner, Y. Schwartz, and S.A. Ben-Haim Evaluation of inotropic changes in ventricular function by NOGA mapping: comparison with echocardiography J Appl Physiol 93 2002 418 426 (Pubitemid 34810200)
35. T. Wolf, L. Gepstein, U. Dror, G. Hayam, R. Shofti, and A. Zaretzky Detailed endocardial mapping accurately predicts the transmural extent of myocardial infarction J Am Coll Cardiol 37 2001 1590 1597
36. T. Wolf, L. Gepstein, G. Hayam, A. Zaretzky, R. Shofty, and D. Kirshenbaum Three-dimensional endocardial impedance mapping: a new approach for myocardial infarction assessment Am J Physiol Heart Circ Physiol 280 2001 H179 H188
37. S.M. Hashemi, S. Ghods, F.D. Kolodgie, K. Parcham-Azad, M. Keane, and D. Hamamdzic A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction Eur Heart J 29 2008 251 259
38. F. Nayeri, L. Brudin, I. Nilsson, and P. Forsberg Sample handling and stability of hepatocyte growth factor in blood samples Cytokine 19 2002 201 205